InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 06/26/2019 10:20:32 AM

Wednesday, June 26, 2019 10:20:32 AM

Post# of 40491
News: $INO Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer

PLYMOUTH MEETING, Pa. , June 26, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial ("REVEAL 1") of VGX-3100, a novel DNA-based immunotherapy being tested t...

Read the whole news https://marketwirenews.com/news-releases/inovio-completes-enrollment-of-vgx-3100-phase-3-trial-reveal-1-for-the-treatment-of-hpv-related-cervical-pre-cancer-8417866.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News